miR-590 promotes the proliferation of HUMSCs and induces ECM synthesis by targeting Smad7

Tianming Liu, Yinge Wu, Teng‐Yi Huang, Xuexuan Zhang, Yingmu CaiOncology 2017 · DOI

Abstract

MicroRNA (miR)-590 is known to promote proliferation in various cancer cell lines, but its role in non-cancerous cells like human umbilical cord mesenchymal stem cells (HUMSCs) is less understood. This study investigates the effects of miR-590 on HUMSC proliferation and extracellular matrix (ECM) synthesis. Through transfection of miR-590 mimics, bioinformatic analysis, and dual-luciferase assays, we identified Smad7 as a direct target. Our findings reveal that miR-590 downregulates Smad7, leading to enhanced cell proliferation and ECM accumulation, suggesting a potential therapeutic pathway for tissue regeneration.

Introduction

Tissue repair and regeneration, particularly for chronic wounds, remain significant clinical challenges. Mesenchymal stem cells (MSCs), especially those from the umbilical cord (HUMSCs), are promising candidates for regenerative medicine due to their high self-renewal capacity and low immunogenicity. MicroRNAs are critical regulators of gene expression in wound healing. While miR-590 has been characterized as a tumor promoter, its ability to stimulate growth and matrix production in stem cells offers a novel approach to enhancing tissue repair.

Materials and Methods

HUMSCs were transfected with miR-590 mimics or siRNAs targeting specific genes. Bioinformatic tools (TargetScan, microRNA.org, miRBase) predicted potential targets, with Smad7 emerging as a primary candidate. Direct interaction was confirmed via a dual-luciferase reporter assay using the 3'-UTR of Smad7. Functional outcomes were assessed using EdU proliferation assays, Western blotting, and immunofluorescence for ECM components like Collagen I and Fibronectin.

Results

miR-590 Upregulation and Target Identification

Transfection with miR-590 mimics achieved a significant increase in microRNA levels, ranging from 66-fold to 138-fold compared to controls.

Expression levels of miR-590 relative to U6 following transfection with mimics at 50 nM and 100 nM concentrations.

Bioinformatic analysis and luciferase assays confirmed that miR-590 directly targets the 3'-UTR of Smad7. Overexpression of miR-590 resulted in a ~51.55% reduction in Smad7 mRNA and a corresponding decrease in Smad7 protein levels.

Enhanced Proliferation and ECM Synthesis

The reduction of Smad7—a known inhibitor of the TGF-β pathway—effectively accelerated the cell cycle. Proliferation rates increased to 38.15% and 60.14% with 50 nM and 100 nM miR-590 treatments, respectively.

DAPI staining of HUMSCs (x200 magnification) visualizing cell nuclei and density across different experimental conditions.

Furthermore, ECM accumulation was significantly boosted, with Collagen I and Fibronectin levels increasing by up to 52% and 152%, respectively. Morphologically, HUMSCs transitioned toward a fibroblast-like appearance, indicative of active matrix deposition.

Discussion

This study demonstrates that miR-590 acts as a molecular switch to promote HUMSC activity by silencing Smad7. By removing this "brake" on the TGF-β signaling pathway, miR-590 induces a high-growth state conducive to wound repair. The observation that Smad7 siRNA mimics the effects of miR-590 overexpression confirms Smad7 as the central mediator of these effects.

However, several considerations remain. These in vitro findings must be validated in vivo to account for complex physiological environments. Additionally, given miR-590's known role in oncogenesis, therapeutic applications must ensure precise control to avoid tumorigenic risks.

Conclusion

miR-590 significantly enhances the proliferative and biosynthetic capabilities of HUMSCs by targeting Smad7. This mechanism highlights miR-590 as a potential target for developing advanced stem cell therapies in regenerative medicine.

Summary updated

Abstract

MicroRNA (miR)-590 has been established to be a promoter of cell proliferation, migration and invasion, and an inhibitor of apoptosis in numerous cancer cell lines. However, its effects on non-cancer cells remain to be elucidated. miR-590 was transfected into human umbilical cord mesenchymal stem cells (HUMSCs), and the cell proliferation rate was determined using a Cell-Light 5-ethynyl-20-deoxyuridine Apollo 567 kit and the presence of extracellular matrix (ECM) proteins were detected using western blot analysis and immunofluorescence microscopy. Using bioinformatic analysis and dual-luciferase assays, the novel target miR-590 was identified. In addition, the effects of miR-590 on cell proliferation and ECM enhancement were also evaluated. The results of the present study demonstrated that miR-590 interacts directly with the 3'-untranslated region of Mothers Against Decapentaplegic Homolog 7 (Smad7), which is an important factor in transforming growth factor-β signaling pathway. Overexpression of miR-590 downregulated Smad7 expression at the mRNA and protein level, and subsequently resulted in cell proliferation and ECM accumulation. Additionally, the transfection of small interfering RNA targeting Smad7 in HUMSCs produced similar effects on cell proliferation and ECM to the overexpression of miR-590. The results of the present study indicated that miR-590 affects HUMSC proliferation by directly targeting Smad7.
BibTeX
@inproceedings{liu2017mir,
  author = {Tianming Liu and Yinge Wu and Teng‐Yi Huang and Xuexuan Zhang and Yingmu Cai},
  title = {{miR-590 promotes the proliferation of HUMSCs and induces ECM synthesis by targeting Smad7}},
  booktitle = {Oncology},
  year = {2017},
  doi = {10.3892/ol.2017.6663},
}
Figure